Clinical Trial

President Trump Clears the Path for Medical Marijuana Reform – But Why Is DEA Attorney Aarathi Haig Still Practicing Law with Ethical Violations

"DEA has already admitted its tribunal system was unconstitutional. Yet dirty cops and unethical attorneys like Aarathi Haig are still...

Smart Sleep Tracker Market is expected to generate a revenue of USD 68.31 Billion by 2032, Globally, at 12.4% CAGR: Verified Market Research®

The Smart Sleep Tracker Market is experiencing rapid growth, driven by rising health awareness, increasing adoption of wearable devices, and...

Deep EigenMatics Receives United States Patent for Inventing Breakthrough Artificial Intelligence Method for Protein Design and Drug Discovery

SUGAR LAND, Texas, Sept. 26, 2025 /PRNewswire/ -- Deep EigenMatics, a startup developing innovative Artificial Intelligence methods for drug discovery and...

UPDATE — ADvantage Therapeutics Awarded $2.5 Million NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the Clinic

MIAMI, Sept. 26, 2025 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc., a biotechnology company developing novel therapies for neurodegenerative diseases, today...

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Patent supports AIM’s strategy to expand international market protection, providing opportunities for licensing, collaborations, and long-term revenue growth Japan is...

CytoDyn to Present on Leronlimab Induction of PD-L1 and Immune Checkpoint Inhibitor Responses in Metastatic Triple-Negative Breast Cancer at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity

RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites

First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer Center Baptist Health Miami Cancer Institute and University of...

Nexalin Technology Announces Issuance of U.S. Patent Covering HALO™ Clarity Device Featuring DIFS™ Technology

HOUSTON, TX, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader...

Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion

Beta version of PredicTcell™ expands training dataset to ~1.4 million and total dataset to over 6.7 billion records.Potential future T...

error: Content is protected !!